Literature DB >> 32558472

Empirical Antituberculosis Therapy in Advanced HIV Disease - Too Much, Too Late.

Richard E Chaisson1.   

Abstract

Entities:  

Year:  2020        PMID： 32558472     DOI： 10.1056/NEJMe2009679

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.

Authors:  Amita Gupta; Xin Sun; Sonya Krishnan; Mitch Matoga; Samuel Pierre; Katherine McIntire; Lucy Koech; Sharlaa Faesen; Cissy Kityo; Sufia S Dadabhai; Kogieleum Naidoo; Wadzanai P Samaneka; Javier R Lama; Valdilea G Veloso; Vidya Mave; Umesh Lalloo; Deborah Langat; Evelyn Hogg; Gregory P Bisson; Johnstone Kumwenda; Mina C Hosseinipour
Journal:  Open Forum Infect Dis       Date:  2022-07-03       Impact factor: 4.423
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.